Major Interest in Shares





RNS Number : 3078P
Oxford Biomedica PLC
23 March 2009
 



For immediate release

23 March 2009

Oxford BioMedica Plc

Notification of Major Interest in Shares

OxfordUK -     23 March 2009: Oxford BioMedica (LSE:OXB), a leading gene therapy company, announces that Spreadex Limited has acquired an interest in its ordinary share capital amounting to 3.13 per cent of presently issued shares. This is connected with the change in interest in Oxford BioMedica by Credit Agricole Cheuvreux International Limited that was announced on 20 March 2009. Spreadex Limited has converted a Contract For Difference (CFD) over Oxford BioMedica plc shares into a fully paid up holding of the underlying stock. 

 

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Oxford BioMedica Plc

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights


Yes

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 

An event changing the breakdown of voting rights

Other (please specify):______________

3. Full name of person(s) subject to notification obligation:

Spreadex Limited

4. Full name of shareholder(s) (if different from 3):

5. Date of transaction (and date on which the threshold is crossed or reached if different):

18/03/09

6. Date on which issuer notified:

20/03/09

7. Threshold(s) that is/are crossed or reached:

3%

8: Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

GB0006648157

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

0

Number of voting rights

0

Number of shares

16,880,025

Number of voting rights

Percentage of voting rights

Direct

16,880,025

Indirect

-

Direct

3.13%

Indirect

-

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

Total (A+B)

Number of voting rights

Percentage of voting rights

16,880,025

3.13%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Proxy Voting:

10. Name of proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14 Contact name:

Andrew Wood 

15. Contact telephone name:

01865 783000


This information is provided by RNS
The company news service from the London Stock Exchange
 

END

 
 

HOLILFISVSIVFIA